NEURACAP
M&A UpdateUpdated · 7 pages · Free to read

Medical Imaging Equipment M&A update, 14–28 September 2026

A bi-weekly briefing on the Medical Imaging Equipment sector covering price moves, product and leadership news, and M&A activity for the two weeks ended September 28, 2026. Built for operators, acquirers and advisors tracking the sector's public names and deal record.

For information only. Not an appraisal or a fairness opinion.

The deeper read: Medical Imaging Equipment Sector Outlook — September 2026

Key figures

Sector Median Move
0.0%
7 covered names, close-to-close
S&P 500 Return
+0.8%
same two-week window
Butterfly Network (BFLY)
+23.5%
two-week return through Sep 28
CY2027E EV/EBITDA (Sector Median)
9.2x
NeuraCap sector study

Read the report

NeuraCap

BI-WEEKLY INDUSTRY EVENTS & M&A UPDATE

HEALTH CARE › HEALTH CARE EQUIPMENT AND SERVICES › MEDICAL IMAGING EQUIPMENT

Companies Invest in the Software Layer While Deal Flow Pauses

This update covers the Medical Imaging Equipment sector over the two-week period September 14–28, 2026: what moved, what companies announced, and what the transaction record showed.

September 14–28, 2026

Prepared by NeuraCap AI · Confidential

Market data through 2026-09-28 · events and transactions from the two-week period 2026-09-14 → 2026-09-28

Medical Imaging Equipment Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice

1

1 / 7

Executive summary

Over September 14–28, 2026, the Medical Imaging Equipment set finished flat, with a 0.0% median move versus the S&P 500's +0.8% return; Butterfly Network (BFLY) was the exception, gaining +23.5%. Companies focused on software and data: GE HealthCare launched an AI operations tool, Philips installed its first U.S. Rembra CT, and Alphatec added a data intelligence leader. No new transactions were announced, leaving the 22-deal precedent set as the pricing reference.

Key findings

  • Price action was flat: 3 of 7 covered names rose, median move 0.0%
  • Butterfly Network (BFLY) drove the period's only outsized move, +23.5%
  • Companies invested in software, imaging launches and leadership hires
  • No new M&A; the trailing set of 22 precedent transactions remains the reference

What each page shows

The analyst’s walkthrough of the deck, page by page.

  1. 01
    BI-WEEKLY INDUSTRY EVENTS & M&A UPDATE

    HEALTH CARE › HEALTH CARE EQUIPMENT AND SERVICES › MEDICAL IMAGING EQUIPMENT

    Cover slide introducing the Medical Imaging Equipment bi-weekly industry events and M&A update for September 14–28, 2026.

    This bi-weekly update covers the Medical Imaging Equipment sector for September 14–28, 2026, tracking what moved, what companies announced, and what transacted. We'll walk through the price action, the product and leadership news, and the deal record to show what it means for you.

    Everything on this page

    BI-WEEKLY INDUSTRY EVENTS & M&A UPDATE HEALTH CARE › HEALTH CARE EQUIPMENT AND SERVICES › MEDICAL IMAGING EQUIPMENT Companies Invest in the Software Layer While Deal Flow Pauses This update covers the Medical Imaging Equipment sector over the two-week period September 14–28, 2026: what moved, what companies announced, and what the transaction record showed. September 14–28, 2026 Prepared by NeuraCap AI · Confidential Market data through 2026-09-28 · events and transactions from the two-week period 2026-09-14 → 2026-09-28 Medical Imaging Equipment Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 1

  2. 02
    THE BI-WEEKLY BOTTOM LINE

    Product and Software Announcements Outpaced the Price Action

    Summarizes the two-week period, showing the covered set finished flat on price while product and software announcements were the main activity.

    Across the 7 names we cover, the median move was 0.0% against a +0.8% S&P 500 return, so price action was muted this period. The real activity sat in what companies did: GE HealthCare launched an AI-enabled operations application, Philips put its first U.S. Rembra CT into service, and Alphatec added a data intelligence leader. Butterfly Network was the one name that moved, up +23.5% on the window, including a +22.0% single-day gain. So what: this period's fundamentals story is being written in product and software, not in stock prices.

    Everything on this page

    THE BI-WEEKLY BOTTOM LINE Product and Software Announcements Outpaced the Price Action The two-week period in one page · 7 covered names, close-to-close · September 14–28, 2026 Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. Driver attributions use calibrated language and are NeuraCap reads of the recorded evidence. Medical Imaging Equipment Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 2 1 The Set Finished Flat: 3 of 7 Covered Names Rose; The Median Move Was 0.0% The S&P 500 returned +0.8% over the same two-week period. Direction was mixed across the covered names and the middle of the set did not move. 2 Butterfly Network Carried the Period's Only Outsized Move Butterfly Network, Inc. (BFLY) returned +23.5% over the window, including +22.0% in the Sep 22 session on higher-than-average trading volume, as reported the following day. 3 Companies Spent the Period on Software, Launches and Leadership GE HealthCare Technologies Inc. (GEHC) launched an AI-enabled operations application, Koninklijke Philips N.V. (PHG) put its first U.S. Rembra CT into service at a regional hospital, and Alphatec Holdings, Inc. (ATEC) added a data intelligence leader. 4 The Transaction Record Stood Still No material sector transactions were announced during the period. The trailing set of 22 precedent transactions remains the reference point for pricing conversations. +23.5% Best mover — Butterfly Network, Inc. (BFLY) worst: ATEC -7.5% · 3 up / 3 down of 7 covered 0.0% Sector median two-week return vs S&P 500 +0.8%

  3. 03
    PUBLIC MARKET MOVERS

    One Name Did the Moving; The Rest of the Set Held the Line

    Shows which covered names moved and which held steady over the two-week window.

    Butterfly Network (BFLY) was the standout, returning +23.5% for the period, including a +22.0% move in the Sep 22 session on higher-than-average volume. The sector median move was 0.0%, versus +0.8% for the S&P 500, so the rest of the set held the line. Our materiality bar for this period sits at 5.9% on a sector-relative basis, which is how we separate signal from noise. So what: when one name clears that bar and the rest don't, it tells us where the market's attention is concentrated.

    Everything on this page

    PUBLIC MARKET MOVERS One Name Did the Moving; The Rest of the Set Held the Line Bi-Weekly moves, close-to-close · September 14–28, 2026 · sector median 0.0% · S&P 500 +0.8% · materiality bar ±5.9% (sector-relative) Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. Attribution links each move only to filings and headlines recorded in the window; where no driver is recorded, the page says so. Calibrated language throughout — NeuraCap reads, not asserted causation. Medical Imaging Equipment Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 3 Bi-Weekly return per company · teal above zero, amber below · sector median 0.0% Butterfly Network, Inc. (BFLY) +23.5% No notable in-window news was identified that clearly explains the move. At +23.5%, Butterfly Network, Inc. (BFLY) stands well clear of the 0.0% median across the covered set. Point-of-care ultrasound remains the most price-sensitive corner of this set. UNEXPLAINED Alphatec Holdings, Inc. (ATEC) -7.5% Shares eased after a Sep 14 note flagging a 19.7% single-session surge; the pullback is consistent with that run giving back ground. Alphatec Holdings, Inc. (ATEC) also named Tommy Carls EVP, Data Intelligence and Strategy on Sep 23. Data and workflow hires show where spine and navigation players think attach value now sits. COMPANY-SPECIFIC Mirion Technologies, Inc. (MIR) -6.7% No notable in-window news was identified that clearly explains the move. The -6.7% decline over the two-week period sits below the 0.0% median for the covered set. A Premium-tier name can slip while the median holds flat; tier position reflects the standing view. UNEXPLAINED

  4. 04
    MAJOR NEWS & INDUSTRY CATALYSTS

    Software, Sensors and Boardrooms: What Companies Actually Did

    Details the period's highest-impact company announcements across software, sensors and leadership.

    GE HealthCare Technologies launched an AI-enabled operations application, Philips put its first U.S. Rembra CT into service at a regional hospital, and Alphatec Holdings added a data intelligence leader. Each of these moves points toward investment in the software and data layer rather than in new hardware alone. None of these announcements produced an outsized price reaction on their own, consistent with a market still digesting the shift. So what: this is the evidence to bring into any conversation about where the sector's next competitive edge is being built.

    Everything on this page

    MAJOR NEWS & INDUSTRY CATALYSTS Software, Sensors and Boardrooms: What Companies Actually Did The two-week period's highest-impact events · titles link to the underlying filing or article · September 14–28, 2026 Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. "Why it matters" lines are NeuraCap reads; each event links to its source. Sources are admitted in a fixed reliability order (SEC filings, press releases, established outlets); video and social platforms are never used. Medical Imaging Equipment Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 4 Sep 23 · NEWS · Business Wire Alphatec hires Tommy Carls as EVP of Data Intelligence and Strategy The hire points at the data and workflow layer, where switching costs build on top of installed hardware. NeuraCap reads it as a capability built in-house rather than bought. Capability gaps in data and workflow are being filled with hires as often as with transactions. Sep 22 · NEWS · Business Wire GE HealthCare appoints Pascal Desroches, a veteran finance executive, to its Board Board additions with finance depth speak to capital allocation discipline at scale. For a Core-tier name, the signal is governance rather than modality mix. Governance moves at the largest platforms frame how capital gets allocated across modalities. Sep 17 · NEWS · Business Wire Philips completes its first U.S. Rembra CT install at a regional medical center A first U.S. install is how a new CT platform begins building installed base, and installed base is what carries service, parts and upgrade revenue later. Early placements in community hospitals are where replacement-cycle share is won. Sep 16 · NEWS · GlobeNewsWire Philips-led projects collect innovation awards for AI-enabled healthcare work Recognition for connected care and fiber-optic sensing work indicates where the R&D is going: the software and sensing layers around the system, not the box. The software layer is becoming the separator between otherwise comparable systems. Sep 15 · NEWS · Business Wire GE HealthCare launches CareIntellect for Operations, an AI capacity-planning application A subscription application sold into the same hospital customers adds recurring revenue on top of equipment and service. That is the attach economics the sector's value drivers reward. Software subscriptions extend the annuity beyond service contracts and parts. Sep 24 · NEWS · Business Wire A law firm says it is investigating the price and process of Varex Imaging's proposed sale Process scrutiny is a familiar feature in sales of component and subsystem specialists, where owned core technology carries much of the value. It is a reminder that process discipline shapes outcomes as much as price. Component and subsystem assets remain the part of the stack that draws buyer attention.

  5. 05
    M&A & STRATEGIC ACTIVITY

    No New Transactions; The Pending Varex Sale Draws Process Scrutiny

    Notes that no new transactions were announced in the period and that the pending Varex sale remains under process scrutiny.

    No new sector transactions were announced during the two-week window, so the trailing set of 22 recorded precedent deals remains the reference point for pricing conversations. The pending Varex transaction continues to draw scrutiny on process, which is worth watching for advisors and acquirers alike. So what: with the deal record static, any near-term activity is more likely to be compared against the existing 22-deal set than to redefine it.

    Everything on this page

    M&A & STRATEGIC ACTIVITY No New Transactions; The Pending Varex Sale Draws Process Scrutiny September 14–28, 2026 · precedent transactions: 22 recorded deals Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. Deal multiples are LTM at announcement where disclosed; "why the deal happened" is a NeuraCap read of the recorded evidence. No old transactions are re-presented as news. Medical Imaging Equipment Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 5 No Material Transactions Announced No material sector transactions were announced during the period. The one observable process item was a law firm's statement on Sep 24 that it is investigating the price and process of Varex Imaging Corporation's (VREX) proposed sale. A quiet two-week period is information: buyer appetite, financing conditions and seller expectations all read through a period with no new deals. The precedent transactions alongside still frame what buyers have paid. 22 Recorded precedent transactions the reference set buyers and sellers price against

  6. 06
    WHAT IT MEANS

    What a Flat Two Weeks of Product News Means for You

    Translates the flat price action and busy product news into implications for owners, acquirers and advisors.

    For owners and operators, the two weeks were about attach economics — a software subscription launch, a first CT install, and a data intelligence hire — the layers that compound over time. For acquirers, the reference set is unchanged: with no new transactions recorded, the trailing set of 22 precedent deals still frames pricing. For advisors, the evidence to lead with is the software and data shift across GE HealthCare, Philips and Alphatec. So what: this period's conversation is about where value is being built, not about what traded.

    Everything on this page

    WHAT IT MEANS What a Flat Two Weeks of Product News Means for You The two-week period translated for the people who act on it · NeuraCap view · observations, not recommendations Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. This page is analytical interpretation drawn from the two-week period's recorded evidence. It is not investment advice. Medical Imaging Equipment Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 6 Sector study 2026-09-28 EV / EBITDA (CY2027E) median 9.2x 9 companies in the study 3 valuation tiers Standing thesis: Medical Imaging Equipment Splits Between Broad Platforms and Radiation Instrumentation FOR OWNERS & OPERATORS Attach Economics Did the Talking Companies in the space spent the two-week period on the layers that compound: a software subscription launch, a first CT install and a data intelligence hire. FOR ACQUIRERS The Reference Set Is Unchanged No new transactions entered the record during the period, so the trailing set of 22 precedent transactions stands as the pricing reference. FOR ADVISORS Lead with the Software and Data Layer The evidence to carry into conversations is the shift toward software and data: GE HealthCare Technologies Inc.'s (GEHC) operations application, Koninklijke Philips N.V.'s (PHG) AI innovation awards, and Alphatec Holdings, Inc.'s (ATEC) data intelligence hire.

  7. 07
    SOURCES & METHODOLOGY

    Sources, Methodology and Important Notice

    Explains the sources and methodology behind the update and where each figure and claim originates.

    Every figure in this update links back to the filing, price record or article it was taken from, and the publishers and filings drawn on for the period are listed on this page. This is how we keep the read calibrated: the evidence sits behind each number and each attribution. So what: you can trace any claim in this deck back to its primary source before you act on it.

    Everything on this page

    SOURCES & METHODOLOGY Sources, Methodology and Important Notice How this bi-weekly update is built and what each kind of statement rests on · September 14–28, 2026 · market data through 2026-09-28 Every figure in this update links to the record it was taken from; the publishers and filings drawn on for the period are listed above. Medical Imaging Equipment Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice 7 OBSERVED DATA Bi-Weekly stock moves are computed close-to-close over the stated window from the platform’s price series. Deal records, values and multiples come from the platform’s transaction record (SEC 8-K extractions) exactly as recorded; each figure links to its citation. Treasury rates come from the platform’s Treasury series and are shown only when the 10-year moved at least ten basis points over the window (it did not in this window, so no rate figures appear). UNIVERSE QUALITY The update universe is the platform’s approved company set for this sector, subject to a $100M market-cap floor so small, loosely related names cannot dominate the statistics. 2 names below the floor were excluded from movers and statistics for this window. EVENTS & NEWS Company events are in-window 8-K filings; news items are publisher-sourced headlines fetched for the window (and any externally supplied items, marked as such). Operational and strategic developments (deals, partnerships, launches, expansion, guidance, leadership, regulatory outcomes) are shown first; capital-return mechanics and conference appearances are limited to one each. Every event links to its source. The deck never asserts an event that has no linked record. SOURCE HIERARCHY News is admitted in a fixed order of reliability: SEC filings first, then company press releases and investor-relations communications, then transaction documents, then established outlets (Reuters, CNBC, The Wall Street Journal, Barron’s and peers). Video and social platforms — including YouTube — are never used as sources. DRIVER ATTRIBUTION A stock move is linked to an event only when the event falls inside the window, and only in calibrated language ("the move appears to reflect…", "shares moved following…"). Where no driver is recorded, the page says so and compares the move to the sector median instead. ANALYTICAL INTERPRETATION "Why it matters", "why the deal happened" and the what-it-means page are NeuraCap analytical views drawn from the recorded evidence, and are labeled as such. INHERITED CONTEXT The standing sector view (thesis, valuation lens, sector median and tiering) is inherited from the NeuraCap sector study run_20260929T155554Z_525_prod (market data as of 2026-09-28) — distilled, never re-derived. That report’s own sources page governs its content; this update reads the period against it. IMPORTANT NOTICE This report is informational only. It is not investment advice, not a recommendation to buy or sell any security, and not an offer of any kind. Readers should perform their own diligence before acting on anything described here. Linked sources this two-week period: businesswire.com · globenewswire.com

Sources and methodology

This update covers Medical Imaging Equipment over the 14-day window September 14–28, 2026; market data runs through September 28, 2026. The universe is the 7 listed companies whose core business is Medical Imaging Equipment under NeuraCap's industry classification, subject to a $100M market-capitalisation floor so that very small, loosely related names cannot dominate the movers and statistics. Companies covered: Alphatec Holdings, Inc. (ATEC), Butterfly Network, Inc. (BFLY), GE HealthCare Technologies Inc. (GEHC), Globus Medical, Inc. (GMED), Mirion Technologies, Inc. (MIR), Koninklijke Philips N.V. (PHG), Varex Imaging Corporation (VREX). 2 names below the floor were excluded from the statistics: HYPR, NNOX.

Window and company universe

This update covers Medical Imaging Equipment over the 14-day window September 14–28, 2026; market data runs through September 28, 2026. The universe is the 7 listed companies whose core business is Medical Imaging Equipment under NeuraCap's industry classification, subject to a $100M market-capitalisation floor so that very small, loosely related names cannot dominate the movers and statistics. Companies covered: Alphatec Holdings, Inc. (ATEC), Butterfly Network, Inc. (BFLY), GE HealthCare Technologies Inc. (GEHC), Globus Medical, Inc. (GMED), Mirion Technologies, Inc. (MIR), Koninklijke Philips N.V. (PHG), Varex Imaging Corporation (VREX). 2 names below the floor were excluded from the statistics: HYPR, NNOX.

How the moves and statistics are computed

Each company's period move is the change in closing price from the last close before the window to the last close inside it (close-to-close). The sector median is the median of those moves across the covered names; the index return is computed the same way for the S&P 500 over the same dates. The largest single-day move inside the window is shown for each mover. Movers are the largest gainers and losers by period move; the attribution cards prefer movers whose in-window record explains the move. Movers carry the valuation tier assigned in the standing sector study (the latest NeuraCap sector outlook) where that study rated them.

Events, news and how a move is attributed

Company events are the 8-K filings made inside the window; news items are publisher-sourced headlines for the window, admitted in a fixed order of reliability: SEC filings first, then company press releases and investor-relations communications, then established outlets (Reuters, CNBC, The Wall Street Journal, Barron's and peers). Video and social platforms are never used. A move is linked to an event only when the event falls inside the window and only in calibrated language; where nothing in the record explains a move, the update says so rather than speculating. Every event links to its source.

Transactions in the window and the trailing record

Transactions are taken from SEC filings by announcement date; 0 were announced inside the window. The trailing record of 22 recorded transactions provides the reference multiples (EV over last-twelve-month revenue or EBITDA at announcement, as disclosed). A value whose own citation describes something other than the price paid is not shown as the deal value; transactions where the acquirer and the target are the same entity are treated as reorganisations and excluded.

Sources

Prices and index levels are market data through September 28, 2026; filings are the companies' SEC filings on EDGAR; press releases are the companies' own; other news items are from the established outlets named on each card; Treasury yields are published by the U.S. Department of the Treasury. Every figure and every event in the update links to its record.

Interpretation and important notice

'Why it matters', 'why the deal happened' and the what-it-means page are NeuraCap analytical views drawn from the recorded evidence, labelled as such. The update is informational: it is not investment advice, not a recommendation to buy or sell any security and not an offer of any kind.

This report is published for information only. It is not a recommendation to buy or sell any security, an offer or solicitation, an appraisal or a fairness opinion, and no fiduciary relationship is created by reading it. Multiples that fail NeuraCap’s plausibility gates are excluded and never plotted. See the full methodology and the disclaimer.

Want this analysis for a company in Medical Imaging Equipment?

Company valuation reports run the same method against a single business — public or private.